UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $533,998,000 | -18.1% | 14,499 | +0.2% | 0.01% | -30.0% |
| Q2 2020 | $652,108,000 | +225542.9% | 14,472 | +137.2% | 0.01% | +150.0% |
| Q1 2020 | $289,000 | +4.0% | 6,100 | +57.3% | 0.00% | +100.0% |
| Q4 2019 | $278,000 | +150.5% | 3,877 | -73.3% | 0.00% | +100.0% |
| Q3 2016 | $111,000 | -78.1% | 14,500 | -66.1% | 0.00% | -80.0% |
| Q1 2016 | $508,000 | +174.6% | 42,795 | +282.1% | 0.01% | +150.0% |
| Q4 2015 | $185,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |